本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corbus Pharmaceuticals Holdings, Inc.

6.84
-1.2414-15.36%
成交量:316.26萬
成交額:2,125.79萬
市值:1.32億
市盈率:-1.12
高:8.08
開:8.08
低:6.33
收:8.08
52周最高:20.56
52周最低:6.33
股本:1,934.13萬
流通股本:1,741.65萬
量比:1.32
換手率:18.16%
股息:- -
股息率:- -
每股收益(TTM):-6.0889
每股收益(LYR):-5.9000
淨資產收益率:-95.58%
總資產收益率:-53.00%
市淨率:1.29
市盈率(LYR):-1.16

資料載入中...

2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/03/21

重要事件披露

Form 8-K - Current report
2025/03/18

重要事件披露

Form 8-K - Current report
2025/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/14

重要事件披露

Form 8-K - Current report
2025/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report